These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 26580477)

  • 41. Non-spherical micro- and nanoparticles: fabrication, characterization and drug delivery applications.
    Mathaes R; Winter G; Besheer A; Engert J
    Expert Opin Drug Deliv; 2015 Mar; 12(3):481-92. PubMed ID: 25327886
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug delivery systems based on nucleic acid nanostructures.
    de Vries JW; Zhang F; Herrmann A
    J Control Release; 2013 Dec; 172(2):467-83. PubMed ID: 23742878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein nanoparticles for therapeutic protein delivery.
    Herrera Estrada LP; Champion JA
    Biomater Sci; 2015 Jun; 3(6):787-99. PubMed ID: 26221839
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nanocarriers for oral drug delivery.
    Zhang L; Wang S; Zhang M; Sun J
    J Drug Target; 2013 Jul; 21(6):515-27. PubMed ID: 23621127
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct delivery of functional proteins and enzymes to the cytosol using nanoparticle-stabilized nanocapsules.
    Tang R; Kim CS; Solfiell DJ; Rana S; Mout R; Velázquez-Delgado EM; Chompoosor A; Jeong Y; Yan B; Zhu ZJ; Kim C; Hardy JA; Rotello VM
    ACS Nano; 2013 Aug; 7(8):6667-6673. PubMed ID: 23815280
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipid Nanoparticle Technology for Delivering Biologically Active Fatty Acids and Monoglycerides.
    Tan JYB; Yoon BK; Cho NJ; Lovrić J; Jug M; Jackman JA
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nanostructured lipid carriers: Promising drug delivery systems for future clinics.
    Beloqui A; Solinís MÁ; Rodríguez-Gascón A; Almeida AJ; Préat V
    Nanomedicine; 2016 Jan; 12(1):143-61. PubMed ID: 26410277
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nanotechnological Strategies for Protein Delivery.
    Villegas MR; Baeza A; Vallet-Regí M
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29693640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DNA Nanostructure as Smart Carriers for Drug Delivery.
    Ouyang X; Chao J; Su S; Fan C
    Methods Mol Biol; 2017; 1500():121-132. PubMed ID: 27813005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nanostructuring molecular materials as particles and vesicles for drug delivery, using compressed and supercritical fluids.
    Elizondo E; Veciana J; Ventosa N
    Nanomedicine (Lond); 2012 Sep; 7(9):1391-408. PubMed ID: 22994957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K; Gorki K; Jaroszek H; Jarzabek K; Gabryel B; Okopien B
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formation of nanocarrier systems by dense gas processing.
    Beh CC; Mammucari R; Foster NR
    Langmuir; 2014 Sep; 30(37):11046-54. PubMed ID: 25162492
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization.
    Carbone C; Cupri S; Leonardi A; Puglisi G; Pignatello R
    Pharm Pat Anal; 2013 Sep; 2(5):665-77. PubMed ID: 24237173
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymer Self-Assembled Nanostructures as Innovative Drug Nanocarrier Platforms.
    Pippa N; Pispas S; Demetzos C
    Curr Pharm Des; 2016; 22(19):2788-95. PubMed ID: 26898736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lipid-coated polymeric nanoparticles for cancer drug delivery.
    Krishnamurthy S; Vaiyapuri R; Zhang L; Chan JM
    Biomater Sci; 2015 Jul; 3(7):923-36. PubMed ID: 26221931
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
    Soares AF; Carvalho Rde A; Veiga F
    Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FRET imaging approaches for in vitro and in vivo characterization of synthetic lipid nanoparticles.
    Gravier J; Sancey L; Hirsjärvi S; Rustique E; Passirani C; Benoît JP; Coll JL; Texier I
    Mol Pharm; 2014 Sep; 11(9):3133-44. PubMed ID: 25098740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.